|
|
Paul A. Crossey, Claire C. Pillai, John P. Miell
J Clin Invest. 2002;
110(3):411
doi:10.1172/JCI10077
Abstract |
Full text
| PDF

I
GF binding protein-1 (IGFBP-1) is a secretory product of decidualized endometrium and a major constituent of amniotic fluid. It is thought to modulate the actions of the IGFs on trophoblast cells and is therefore potentially important in regulating placental development and fetal growth. To investigate this hypothesis, we have studied the effects of decidual IGFBP-1 excess on fetoplacental growth in transgenic mice overexpressing human IGFBP-1. Endogenous fetal IGFBP-1 overexpression is associated with a transient impairment of fetal growth in midgestation. Maternal decidual IGFBP-1 excess is also associated with impaired fetal growth in midgestation independent of fetal genotype, indicating placental insufficiency. Our data also demonstrate that amniotic fluid IGFBP-1 is derived almost exclusively from maternal sources. Decidual IGFBP-1 overexpression has a marked effect on placental development. Placental morphology is abnormal in transgenic females due to altered trophoblast invasion and differentiation. These changes result in an increase in placental mass throughout pregnancy. This study provides the first compelling in vivo evidence that IGFBP-1 plays a role in placentation and suggests that IGFBP-1 has a pathological role in preeclampsia, a disorder characterized by shallow uterine invasion and altered placental development.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
Reproductive Medicine and Assisted Reproductive Techniques
Alexander EP Heazell, Justine Nugent, Rebecca L Jones, Lynda K Harris, Philip N Baker
|
Endometrium, The
|
2008 |
Expression pattern of integrins and their ligands in mouse feto-maternal tissues during pregnancy
Sachin S. Mangale, K. V. R. Reddy
|
Reprod. Fertil. Dev.
|
2007 |
Animal Models for Small for Gestational Age and Fetal Programing of Adult Disease
Patricia M. Vuguin
|
Horm Res
|
2007 |
Insulin-like growth factor-binding protein-1: an evolutionarily conserved fine tuner of insulin-like growth factor action under catabolic and stressful conditions
S. Kajimura, C. Duan
|
J Fish Biology
|
2007 |
INSULIN-LIKE GROWTH FACTORS AND PLACENTAL FUNCTION
NATALIA SCHLABRITZ-LOUTSEVITCH, CUN LI, PETER W NATHANIELSZ
|
Fet. Matern. Med. Rev.
|
2007 |
The Role of Insulin-Like Growth Factor Binding Proteins in Development
J. M. Pell, D. A. M. Salih, L. J. Cobb, G. Tripathi, A. Drozd
|
Rev Endocr Metab Disord
|
2005 |
Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface
Kristy Red-Horse, Yan Zhou, Olga Genbacev, Akraporn Prakobphol, Russell Foulk, Michael McMaster, Susan J. Fisher
|
J. Clin. Invest.
|
2004 |
Emerging technologies for the identification of therapeutic targets for the management of pre-eclampsia
DC Pritlove, BK Tan, NCJ de Wit, M Vatish
|
Expert Opin. Ther. Targets
|
2004 |
Functional consequences of IGFBP excess?lessons from transgenic mice
Eckhard Wolf, Marlon R. Schneider, Rui Zhou, Thomas M. Fisch, Nadja Herbach, Maik Dahlhoff, R�diger Wanke, Andreas Hoeflich
|
Pediatr Nephrol
|
2004 |
Understanding Fetoplacental Growth Through Transgenic IGF Models
BARBRA DE VRIJER, TIMOTHY R.H. REGNAULT, RUSSELL V. ANTHONY
|
Pediatric Research
|
2003 |
|